Previous reports demonstrated that SIRT1 was downregulated in bleomycin (BLM)-induced pulmonary fibrosis, and treatment with an SIRT1 activator attenuated the EMT in BLM-induced fibrosis [56]. The gene discussed is SIRT1; the disease is fibrosis.